ArticleCancers2020

Cotargeting of XPO1 Enhances the Antileukemic Activity of Midostaurin and Gilteritinib in Acute Myeloid Leukemia.

Lindsey T Brinton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.